ARTICLE | Clinical News
Brinzolamide/brimonidine tartrate regulatory update
July 30, 2012 7:00 AM UTC
Novartis disclosed in its 2Q12 earnings that its Alcon Inc. ophthalmic unit filed a regulatory application in the U.S. for brinzolamide/brimonidine tartrate to treat intraocular pressure in patients ...